Abbott Labs (ABT) Stock
NASDAQ · ABT
101.08
Fundamentals
Market cap
$175.27B
Price / Earnings ratio
32.2x
Price / Sales ratio
3.8x
Price / Book ratio
3.4x
Return on assets
7.0%
Ex-Dividend date
15 Jul 2026
Last payment date
17 Aug 2026
Dividend amount
$0.63
Dividend yield
2.45%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
NVST vs. ABT: Which Stock Is the Better Value Option?
NeutralABTSeptember 25, 2026
Zacks Investment ResearchNeutral
NVST vs. ABT: Which Stock Is the Better Value Option?
ABT

Zacks Investment Research
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
NeutralABTSeptember 24, 2026
Zacks Investment ResearchNeutral
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
ABT

Zacks Investment Research
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
NeutralABTSeptember 23, 2026
Zacks Investment ResearchNeutral
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
ABT

The Motley Fool
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
NeutralABTSeptember 21, 2026
The Motley FoolNeutral
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
ABT
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy11
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
53B35B18B0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
104B69B34B0
Revenue to Profit
2025$44.3B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$6.5B
Net incomeEarnings
EPS forecast
Actual EPS
$1.26
$1.25
Q2FY25
$1.30
$1.30
Q3FY25
$1.50
Q4FY25
$1.20
Q1FY26
$1.38
Q2FY26
The market is expecting earnings per share of $1.38 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
NVST vs. ABT: Which Stock Is the Better Value Option?
NeutralABTSeptember 25, 2026
Zacks Investment ResearchNeutral
NVST vs. ABT: Which Stock Is the Better Value Option?
ABT

Zacks Investment Research
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
NeutralABTSeptember 24, 2026
Zacks Investment ResearchNeutral
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
ABT

Zacks Investment Research
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
NeutralABTSeptember 23, 2026
Zacks Investment ResearchNeutral
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
ABT

The Motley Fool
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
NeutralABTSeptember 21, 2026
The Motley FoolNeutral
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
ABT

Zacks Investment Research
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
NeutralABTSeptember 21, 2026
Zacks Investment ResearchNeutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
ABT

The Motley Fool
3 Dividend Stocks to Buy and Hold for 10 Years
NeutralABTSeptember 18, 2026
The Motley FoolNeutral
3 Dividend Stocks to Buy and Hold for 10 Years
ABT

The Motley Fool
Why Wall Street Is Becoming Even More Bullish About This Dividend King
NeutralABTSeptember 18, 2026
The Motley FoolNeutral
Why Wall Street Is Becoming Even More Bullish About This Dividend King
ABT

Zacks Investment Research
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
NeutralABTSeptember 16, 2026
Zacks Investment ResearchNeutral
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
ABT

Zacks Investment Research
Abbott (ABT) Rises As Market Takes a Dip: Key Facts
NeutralABTSeptember 14, 2026
Zacks Investment ResearchNeutral
Abbott (ABT) Rises As Market Takes a Dip: Key Facts
ABT

Reuters
Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says
NeutralABTSeptember 14, 2026
ReutersNeutral
Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says
ABT
About Abbott Labs
Abbott is a global healthcare leader that helps people live more fully at all stages of life. We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities.
SectorHealthcare
IndustryMedical Devices
Employees122,000
CEOMr. Robert B. Ford
IPO DateJan 13, 1978
HeadquartersAbbott Park, IL
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Robert B. Ford | Executive Chairman & CEO | 1974 |
| Mr. Philip P. Boudreau | CFO & Executive VP of Finance | 1973 |
| Mr. Daniel Gesua Sive Salvadori | Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 1979 |
| Mr. Christopher J. Scoggins | Executive Vice President of Diabetes Care | 1970 |
| Ms. Lisa D. Earnhardt | Executive VP & Group President of Medical Devices | 1970 |
| Ms. Sabina Ewing | Senior VP of Business & Technology Services and Chief Information Officer | 1974 |
| Mr. Michael Comilla | Vice President of Investor Relations. | — |
| Erica L. Battaglia | VP and Chief Ethics & Compliance Officer | — |
| Ms. Elizabeth C. Cushman | Executive VP, General Counsel & Secretary | 1970 |
| Ms. Melissa Brotz | Senior Vice President of Global Marketing & External Affairs | — |
Fundamentals
Valuation
Market cap$175.27B
Price-to-sales ratio3.75
Price-to-book value3.38
Price-earnings ratio32.20
Return on Equity12.00%
Return on Sales19.00%
Return on Assets7.00%
PEG ratio1.90
Earnings Per Share
Earnings Per Share$3.10
Income Statement
Average volume8,678,587
EBITDA$11.84B
1 year high (52w)$135.45
1 year low (52w)$81.97
Dividend
Ex dividend date15 Jul 2026
Dividend amount$0.63
Dividend yield2.45%
Last payment date17 Aug 2026
Dividend yield (TTM)2.45%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
11 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$124.55
Est return
23.21%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.1 | +10.0 | -2.5 | +11.0 | ||||||||
| 2022 | -8.3 | -5.2 | +0.2 | -4.3 | +4.1 | -5.6 | -1.3 | -6.3 | -7.7 | -0.6 | +8.3 | +1.7 |
| 2023 | +0.9 | -9.0 | +0.4 | +8.7 | -8.2 | +6.0 | +3.8 | -6.9 | -5.8 | -1.2 | +9.8 | +4.9 |
| 2024 | +3.0 | +3.6 | -4.2 | -5.5 | -3.9 | +1.0 | +2.7 | +2.8 | -0.6 | -0.2 | +0.1 | -3.2 |
| 2025 | +12.8 | +7.4 | -5.4 | -0.7 | +2.1 | +1.8 | -7.4 | +4.2 | +1.9 | -7.4 | +4.1 | -2.1 |
| 2026 | -12.0 | +6.3 | -10.0 | -11.3 | -4.3 | +3.4 | +14.7 | +3.0 | -7.0 |
Corporate actions
Upcoming
DividendQ4/26
Ex-dividend date15 Oct 2026
Payable date16 Nov 2026
Amount per share$0.63
Past
DividendQ3/26
Ex-dividend date15 Jul 2026
Payable date17 Aug 2026
Amount per share$0.63
DividendQ2/26
Ex-dividend date15 Apr 2026
Payable date15 May 2026
Amount per share$0.63
DividendQ1/26
Ex-dividend date15 Jan 2026
Payable date13 Feb 2026
Amount per share$0.63
DividendQ4/25
Ex-dividend date15 Oct 2025
Payable date17 Nov 2025
Amount per share$0.59
DividendQ3/25
Ex-dividend date15 Jul 2025
Payable date15 Aug 2025
Amount per share$0.59
DividendQ2/25
Ex-dividend date15 Apr 2025
Payable date15 May 2025
Amount per share$0.59
DividendQ1/25
Ex-dividend date15 Jan 2025
Payable date14 Feb 2025
Amount per share$0.59
DividendQ4/24
Ex-dividend date15 Oct 2024
Payable date15 Nov 2024
Amount per share$0.55
DividendQ3/24
Ex-dividend date15 Jul 2024
Payable date15 Aug 2024
Amount per share$0.55
DividendQ2/24
Ex-dividend date12 Apr 2024
Payable date15 May 2024
Amount per share$0.55
DividendQ1/24
Ex-dividend date11 Jan 2024
Payable date15 Feb 2024
Amount per share$0.55
DividendQ4/23
Ex-dividend date12 Oct 2023
Payable date15 Nov 2023
Amount per share$0.51
DividendQ3/23
Ex-dividend date13 Jul 2023
Payable date15 Aug 2023
Amount per share$0.51
DividendQ2/23
Ex-dividend date13 Apr 2023
Payable date15 May 2023
Amount per share$0.51
DividendQ1/23
Ex-dividend date12 Jan 2023
Payable date15 Feb 2023
Amount per share$0.51
DividendQ4/22
Ex-dividend date13 Oct 2022
Payable date15 Nov 2022
Amount per share$0.47
DividendQ3/22
Ex-dividend date14 Jul 2022
Payable date15 Aug 2022
Amount per share$0.47
DividendQ2/22
Ex-dividend date13 Apr 2022
Payable date16 May 2022
Amount per share$0.47
DividendQ1/22
Ex-dividend date13 Jan 2022
Payable date15 Feb 2022
Amount per share$0.47
DividendQ4/21
Ex-dividend date14 Oct 2021
Payable date15 Nov 2021
Amount per share$0.45



